ROCHE HLDG DR (RHO5 HM) stock market data APIs
€275.6107
0(0%)
as of July 4, 2025
Try our APIs with
free plan!
ROCHE HLDG DR Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for RHO5.HM.
Prev. Close
275.6107
Open
275.6107
High
275.6107
Low
275.6107
52 wk Range
235.4067-293.3
Market Cap
312 681 M
Dividends (Yield)
0.0415
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ROCHE HLDG DR data using free add-ons & libraries
Get ROCHE HLDG DR Fundamental Data
ROCHE HLDG DR Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ROCHE HLDG DR News
New
PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects?
Shares of Prothena Corporation PRTA plummeted 53.5% year to date compared with the industry’s decline of 0.6%. The recent pipeline setbacks have significantly hurt PRTA’s growth prospects.Zacks I...
Switzerland seeks trade deal with Trump without getting into EU bind
By Dave Graham ZURICH (Reuters) -Switzerland is exploring what concessions it can make to secure a deal with Washington on trade, but it must tread carefully to protect its interests with key trading...
FDA Grants Accelerated Approval to Regeneron's Blood Cancer Drug
Regeneron Pharmaceuticals, Inc. REGN obtained FDA approval for linvoseltamab-gcpt for the treatment of relapsed or refractory (R/R) multiple myeloma (MM). The regulatory body granted accelerated appr...
Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern
Hologic’s HOLX Molecular Diagnostics business posted a 7.8% (excluding COVID-19-related sales) growth in the second quarter of fiscal 2025, although results did not reflect its full potential.The pe...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
